ロード中...
Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53
Cisplatin is an important antitumor agent, but its clinical utility is often limited by multifactorial mechanism of resistance. Loss of tumor suppressor p53 function is a major mechanism, affected by either mutation in the DNA binding domain or dysregulation by overexpression of p53 inhibitors MDM2...
保存先:
| 出版年: | Oncogene |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5289310/ https://ncbi.nlm.nih.gov/pubmed/26876197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.12 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|